WallStreetZenWallStreetZen

NASDAQ: ELYM
Eliem Therapeutics Inc Stock Ownership - Who owns Eliem Therapeutics?

Insider buying vs selling

Have Eliem Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Valerie MorissetEVP RD AND CSO2023-09-205,431$0.00
$10.86Buy

1 of 1

ELYM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ELYM insiders and whales buy or sell their stock.

ELYM Shareholders

What type of owners hold Eliem Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP47.44%13,150,849$50.63MInstitution
Ai Eti LLC18.07%5,009,400$19.29MInsider
Bml Capital Management LLC7.86%2,180,000$8.39MInstitution
Ra Capital Management LP3.03%841,087$3.24MInsider
Driehaus Capital Management LLC2.93%811,680$3.12MInstitution
Valerie Morisset1.82%505,307$1.95MInsider
Vanguard Group Inc1.12%310,486$1.20MInstitution
Adam Joseph Rosenberg0.64%178,100$685.69kInsider
Atom Investors LP0.28%78,276$301.36kInstitution
Geode Capital Management LLC0.24%66,626$256.51kInstitution

1 of 3

ELYM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ELYM60.80%23.57%Net Buying
SEER54.70%45.30%Net BuyingNet Selling
CLSD10.37%36.40%Net BuyingNet Buying
OTLK13.26%86.74%Net BuyingNet Buying
PDSB22.71%31.97%

Eliem Therapeutics Stock Ownership FAQ

Who owns Eliem Therapeutics?

Eliem Therapeutics (NASDAQ: ELYM) is owned by 60.80% institutional shareholders, 23.57% Eliem Therapeutics insiders, and 15.63% retail investors. Ai Eti LLC is the largest individual Eliem Therapeutics shareholder, owning 5.01M shares representing 18.07% of the company. Ai Eti LLC's Eliem Therapeutics shares are currently valued at $19.39M.

If you're new to stock investing, here's how to buy Eliem Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.